Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,100,381
-$24,118,607 QoQ
Shares Held
426,685
-69.9% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#92
of 494 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Sep 30, 2025CallValue
$1,472,149
CallShares
97,300
PutValue
$16,643
PutShares
1,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. ROIV ranks #22 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in ROIV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,100,381 | 426,685 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $39,218,988 | 1,415,848 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,212,353 | 839,279 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,288,462 | 1,208,755 | Shares | Sole | 2026-03-31 | |
| 2025-09-30 | $1,472,149 | 97,300 | Call | Sole | 2026-03-31 | |
| 2025-09-30 | $16,643 | 1,100 | Put | Sole | 2026-03-31 | |
| 2025-06-30 | $23,834,550 | 2,114,867 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $15,224,962 | 1,508,916 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $6,741,822 | 569,892 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $5,302,872 | 459,521 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $4,057,949 | 383,912 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $4,710,979 | 446,962 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $4,428,775 | 394,370 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $4,322,184 | 370,050 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $3,933,528 | 390,231 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,711,185 | 231,868 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $1,018,213 | 127,436 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $10,046 | 3,120 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $73,728 | 18,115 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $52,265 | 10,580 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||